We are live on ! Find out more
OFIX icon

Orthofix Medical

154 hedge funds and large institutions have $407M invested in Orthofix Medical in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 61 increasing their positions, 49 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 16

29% more call options, than puts

Call options by funds: $18K | Put options by funds: $14K

24% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 49

8% more capital invested

Capital invested by funds: $376M → $407M (+$31.5M)

7% more funds holding

Funds holding: 144154 (+10)

3.74% more ownership

Funds ownership: 98.46%102.2% (+3.7%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
154
Holders Change
+10
Holders Change %
+6.94%
% of All Funds
2.48%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
61
Reduced
49
Closed
16
Calls
$18K
Puts
$14K
Net Calls
+$4K
Net Calls Change
+$19K
Name Holding Trade Value Shares
Change
Change in
Stake
Franklin Resources
26
Franklin Resources
California
$2.98M +$658K +37,298 +35%
N
27
Nuveen
North Carolina
$2.88M +$15.4K +873 +0.6%
GF
28
Gabelli Funds
New York
$2.85M -$1.51M -85,837 -38%
Citadel Advisors
29
Citadel Advisors
Florida
$2.8M -$1.06M -60,140 -31%
Principal Financial Group
30
Principal Financial Group
Iowa
$2.7M +$83K +4,705 +4%
First Eagle Investment Management
31
First Eagle Investment Management
New York
$2.65M -$511K -28,983 -18%
Arrowstreet Capital
32
Arrowstreet Capital
Massachusetts
$2.26M +$1.19M +67,313 +158%
AllianceBernstein
33
AllianceBernstein
Tennessee
$2.2M +$48K +2,719 +3%
RA
34
Royce & Associates
New York
$1.99M -$1.14M -64,530 -40%
GI
35
GAMCO Investors
Connecticut
$1.73M +$30K +1,700 +2%
Assenagon Asset Management
36
Assenagon Asset Management
Luxembourg
$1.69M +$543K +30,802 +60%
Two Sigma Investments
37
Two Sigma Investments
New York
$1.58M +$997K +56,541 +274%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$1.44M +$127K +7,200 +11%
Federated Hermes
39
Federated Hermes
Pennsylvania
$1.42M +$132K +7,491 +12%
KCM
40
Kennedy Capital Management
Missouri
$1.31M +$1.13M +63,940 New
Deutsche Bank
41
Deutsche Bank
Germany
$1.27M +$2.95K +167 +0.3%
Norges Bank
42
Norges Bank
Norway
$1.25M +$1.07M +60,900 New
TA
43
Teton Advisors
New York
$1.24M -$40.9K -2,320 -4%
SC
44
Shay Capital
New York
$1.22M +$1.05M +59,511 New
GSIS
45
Global Strategic Investment Solutions
Arizona
$1.18M
EGM
46
Engineers Gate Manager
New York
$1.16M +$703K +39,828 +237%
OMC
47
Old Mission Capital
Illinois
$1.15M +$985K +55,810 New
Goldman Sachs
48
Goldman Sachs
New York
$1.14M -$326K -18,501 -25%
Wells Fargo
49
Wells Fargo
California
$1.12M +$939K +53,223 +3,456%
E
50
Ergoteles
New York
$1.08M +$645K +36,580 +229%

OFIX Hedge Fund Activity: Q4 2022 in Review

154 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q4 2022, worth a combined $407M — up 8.4% from $376M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new OFIX positions and 16 closed out — a net gain of 10 holders — while 61 added to existing stakes and 49 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $14.1M. The largest seller was Polar Asset Management Partners, cutting an estimated $12.3M.

  • 154 institutional investors held Orthofix Medical (OFIX) as of Q4 2022, up from 144 in Q3 2022.
  • Funds reported $407M of Orthofix Medical stock for Q4 2022, up 8.4% quarter-over-quarter.
  • 26 funds opened new Orthofix Medical positions in Q4 2022 and 16 closed out, a net change of +10 holders.
  • The largest Orthofix Medical buyer in Q4 2022 was Armistice Capital, an estimated $14.1M added.
  • The largest Orthofix Medical seller in Q4 2022 was Polar Asset Management Partners, an estimated $12.3M sold.

Based on aggregated 13F filings for Q4 2022.